Contact Us
Personalized Gene Therapy Treatment Global Market Report 2025
Global Personalized Gene Therapy Treatment Market Report 2025
Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF
Purchase This Report

Personalized Gene Therapy Treatment Global Market Report 2025

By Therapy (Targeted Treatments, Pharmacogenomics); By Vector Type (Viral, Non-Viral); By Distribution Channel (Hospitals, Clinics, Home Administration, Other Distribution Channels); By Application (Oncology, Neurology, Hematological, Infectious Diseases, Ophthalmology, Other Applications); Subsegments:; By Targeted Treatments (Monoclonal Antibodies, Chimeric Antigen Receptor T-Cell Therapy (CAR-T), Small Interfering RNA (siRNA) Therapy, Antisense Oligonucleotides (ASO), Gene Editing Therapy); By Pharmacogenomics (Companion Diagnostics, Drug Metabolism Enzyme Testing, Genetic Biomarker Analysis, Single Nucleotide Polymorphism (SNP) Profiling, Adverse Drug Reaction (ADR) Prediction) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Personalized Gene Therapy Treatment Market Overview

• Personalized Gene Therapy Treatment market size has reached to $6.93 billion in 2024

• Expected to grow to $17.65 billion in 2029 at a compound annual growth rate (CAGR) of 20.5%

• Growth Driver: The Rising Prevalence Of Genetic Disorders Is Fueling The Growth Of The Market Due To Increasing Cases That Require Targeted, Gene-Based Therapies

• Market Trend: Strategic Partnerships Accelerating Personalized Gene Therapy Innovations

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Personalized Gene Therapy Treatment Market?

Personalized gene therapy treatment refers to professional medical treatment that delivers targeted therapies tailored to an individual’s unique genetic profile. It modifies, repairs, or replaces faulty genes to directly address underlying genetic conditions. Personalized gene therapy treatment enhances treatment precision, minimizes adverse effects, and improves therapeutic effectiveness.

The main types of personalized gene therapy treatments are targeted treatments and pharmacogenomics. Targeted treatments are therapies designed to precisely modify or regulate specific genes associated with a disease to achieve maximum therapeutic effect with minimal side effects. The vector types are viral and non-viral and are distributed through several distribution channels, including hospitals, clinics, home administration, and others, for various applications across multiple medical fields, such as oncology, neurology, hematology, infectious diseases, ophthalmology, and others.

Personalized Gene Therapy Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Personalized Gene Therapy Treatment Market Size 2025 And Growth Rate?

The personalized gene therapy treatment market size has grown exponentially in recent years. It will grow from $6.93 billion in 2024 to $8.38 billion in 2025 at a compound annual growth rate (CAGR) of 20.8%. The growth in the historic period can be attributed to increasing prevalence of genetic disorders, advancements in gene editing technologies, rising awareness about personalized medicine, supportive government initiatives and funding, and growth in biotechnology research and infrastructure.

What Is The Personalized Gene Therapy Treatment Market Growth Forecast?

The personalized gene therapy treatment market size is expected to see exponential growth in the next few years. It will grow to $17.65 billion in 2029 at a compound annual growth rate (CAGR) of 20.5%. The growth in the forecast period can be attributed to the expansion of clinical trials for gene therapies, the integration of AI and predictive analytics in treatment design, increasing partnerships between pharma and biotech companies, the development of safer and more efficient delivery vectors, and the growing demand for targeted and precision therapies. Major trends in the forecast period include integration of artificial intelligence and machine learning in therapy design, expansion of genomic sequencing capabilities, rising collaborations between biotechnology and pharmaceutical companies, automation in gene therapy manufacturing processes, and integration of blockchain technology for genetic data security.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How the Personalized Gene Therapy Treatment Market Segmented?

1) By Therapy: Targeted Treatments, Pharmacogenomics

2) By Vector Type: Viral, Non-Viral

3) By Distribution Channel: Hospitals, Clinics, Home Administration, Other Distribution Channels

4) By Application: Oncology, Neurology, Hematological, Infectious Diseases, Ophthalmology, Other Applications

Subsegments:

1) By Targeted Treatments: Monoclonal Antibodies, Chimeric Antigen Receptor T-Cell Therapy (CAR-T), Small Interfering RNA (siRNA) Therapy, Antisense Oligonucleotides (ASO), Gene Editing Therapy

2) By Pharmacogenomics: Companion Diagnostics, Drug Metabolism Enzyme Testing, Genetic Biomarker Analysis, Single Nucleotide Polymorphism (SNP) Profiling, Adverse Drug Reaction (ADR) Prediction

What Is Driving The Personalized Gene Therapy Treatment Market? The Rising Prevalence Of Genetic Disorders Is Fueling The Growth Of The Market Due To Increasing Cases That Require Targeted, Gene-Based Therapies

The growing prevalence of genetic disorders is expected to propel the growth of the personalized gene therapy treatment market going forward. Genetic disorders are conditions resulting from DNA abnormalities that disrupt normal body functions. The prevalence of genetic disorders is rising due to increasing parental age, as older reproductive cells have a higher risk of mutations that can be passed to offspring. Personalized gene therapy addresses genetic disorders by precisely correcting the defective genes responsible for the condition and tailors treatment to an individual’s genetic makeup, enhancing efficacy and reducing side effects. For instance, in September 2023, according to the Cystic Fibrosis Trust, a UK-based national charity, in the UK, 11,148 patients were registered with cystic fibrosis (CF) in 2022, an increase from 10,908 in 2021. Therefore, the growing prevalence of genetic disorders is driving the growth of the personalized gene therapy treatment industry.

Who Are The Major Players In The Global Personalized Gene Therapy Treatment Market?

Major companies operating in the personalized gene therapy treatment market are Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Vertex Pharmaceuticals Incorporated, Kyowa Kirin Co. Ltd., BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., Rocket Pharmaceuticals Inc., REGENXBIO Inc., Intellia Therapeutics Inc., Beam Therapeutics Inc., Adaptimmune Therapeutics plc, Krystal Biotech Inc., Miltenyi Biomedicine GmbH, Bluebird Bio Inc., uniQure N.V., Mesoblast Limited, Astellas Gene Therapies Inc., Adverum Biotechnologies Inc., Autolus Therapeutics plc.

What Are The Key Trends Of The Global Personalized Gene Therapy Treatment Market? Strategic Partnerships Accelerating Personalized Gene Therapy Innovations

Major companies operating in the personalized gene therapy treatment market are focusing on adopting strategic partnerships to expand technological capabilities and bring innovative therapies to patients more efficiently. Strategic partnerships are collaborative alliances between organizations to leverage each other’s strengths and resources for mutual growth and competitive advantage while sharing risks and benefits. For instance, in May 2025, Aldevron, a US-based company involved in the production of DNA, RNA, and protein, collaborated with Integrated DNA Technologies, a US-based provider of genomics solutions, to manufacture the world’s first mRNA-based personalized CRISPR therapy to treat an infant with a rare and life-threatening genetic condition, urea cycle disorder (UCD). This N of 1 therapy was developed and delivered in just six months by creating a custom guide RNA, an mRNA-encoded base editor, off-target safety services, and a clinically validated lipid nanoparticle delivery system. The therapy's development marks a significant milestone in personalized in vivo base-editing treatments.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Personalized Gene Therapy Treatment Market? GeneDx Acquires Fabric Genomics To Strengthen AI-Driven Genomic Diagnostics

In July 2025, Eli Lilly and Company, a US-based pharmaceutical company, acquired Verve Therapeutics, Inc. for $1.3 billion. With this acquisition, Eli Lilly aims to expand its portfolio into cardiovascular gene-editing therapies and strengthen its presence in the personalized gene therapy industry. Verve Therapeutics is a US-based clinical-stage company developing one-time base-editing gene therapies specifically aimed at cardiovascular disease.

What Is The Regional Outlook For The Global Personalized Gene Therapy Treatment Market?

North America was the largest region in the personalized gene therapy treatment market in 2024. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Personalized Gene Therapy Treatment Market?

The personalized gene therapy treatment market consists of revenues earned by entities by providing services such as genetic testing and diagnostics, personalized therapy design, gene editing treatments, viral and non-viral vector delivery, patient-specific cell therapies, and post-treatment monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The personalized gene therapy treatment market also includes sales of viral vectors, gene editing platforms, cell culture systems, bioprocessing tools, and monitoring software. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Personalized Gene Therapy Treatment Industry?

The personalized gene therapy treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the personalized gene therapy treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Table Of Contents

1. Executive Summary

2. Personalized Gene Therapy Treatment Market Characteristics

3. Personalized Gene Therapy Treatment Market Trends And Strategies

4. Personalized Gene Therapy Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Personalized Gene Therapy Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Personalized Gene Therapy Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Personalized Gene Therapy Treatment Market Growth Rate Analysis

5.4. Global Personalized Gene Therapy Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Personalized Gene Therapy Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Personalized Gene Therapy Treatment Total Addressable Market (TAM)

6. Personalized Gene Therapy Treatment Market Segmentation

6.1. Global Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Targeted Treatments

Pharmacogenomics

6.2. Global Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Viral

Non-Viral

6.3. Global Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Home Administration

Other Distribution Channels

6.4. Global Personalized Gene Therapy Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Neurology

Hematological

Infectious Diseases

Ophthalmology

Other Applications

6.5. Global Personalized Gene Therapy Treatment Market, Sub-Segmentation Of Targeted Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monoclonal Antibodies

Chimeric Antigen Receptor T-Cell Therapy (CAR-T)

Small Interfering RNA (siRNA) Therapy

Antisense Oligonucleotides (ASO)

Gene Editing Therapy

6.6. Global Personalized Gene Therapy Treatment Market, Sub-Segmentation Of Pharmacogenomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Companion Diagnostics

Drug Metabolism Enzyme Testing

Genetic Biomarker Analysis

Single Nucleotide Polymorphism (SNP) Profiling

Adverse Drug Reaction (ADR) Prediction

7. Personalized Gene Therapy Treatment Market Regional And Country Analysis

7.1. Global Personalized Gene Therapy Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Personalized Gene Therapy Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Personalized Gene Therapy Treatment Market

8.1. Asia-Pacific Personalized Gene Therapy Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Personalized Gene Therapy Treatment Market

9.1. China Personalized Gene Therapy Treatment Market Overview

9.2. China Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Personalized Gene Therapy Treatment Market

10.1. India Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Personalized Gene Therapy Treatment Market

11.1. Japan Personalized Gene Therapy Treatment Market Overview

11.2. Japan Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Personalized Gene Therapy Treatment Market

12.1. Australia Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Personalized Gene Therapy Treatment Market

13.1. Indonesia Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Personalized Gene Therapy Treatment Market

14.1. South Korea Personalized Gene Therapy Treatment Market Overview

14.2. South Korea Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Personalized Gene Therapy Treatment Market

15.1. Western Europe Personalized Gene Therapy Treatment Market Overview

15.2. Western Europe Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Personalized Gene Therapy Treatment Market

16.1. UK Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Personalized Gene Therapy Treatment Market

17.1. Germany Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Personalized Gene Therapy Treatment Market

18.1. France Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Personalized Gene Therapy Treatment Market

19.1. Italy Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Personalized Gene Therapy Treatment Market

20.1. Spain Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Personalized Gene Therapy Treatment Market

21.1. Eastern Europe Personalized Gene Therapy Treatment Market Overview

21.2. Eastern Europe Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Personalized Gene Therapy Treatment Market

22.1. Russia Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Personalized Gene Therapy Treatment Market

23.1. North America Personalized Gene Therapy Treatment Market Overview

23.2. North America Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Personalized Gene Therapy Treatment Market

24.1. USA Personalized Gene Therapy Treatment Market Overview

24.2. USA Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Personalized Gene Therapy Treatment Market

25.1. Canada Personalized Gene Therapy Treatment Market Overview

25.2. Canada Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Personalized Gene Therapy Treatment Market

26.1. South America Personalized Gene Therapy Treatment Market Overview

26.2. South America Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Personalized Gene Therapy Treatment Market

27.1. Brazil Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Personalized Gene Therapy Treatment Market

28.1. Middle East Personalized Gene Therapy Treatment Market Overview

28.2. Middle East Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Personalized Gene Therapy Treatment Market

29.1. Africa Personalized Gene Therapy Treatment Market Overview

29.2. Africa Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Personalized Gene Therapy Treatment Market Competitive Landscape And Company Profiles

30.1. Personalized Gene Therapy Treatment Market Competitive Landscape

30.2. Personalized Gene Therapy Treatment Market Company Profiles

30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Vertex Pharmaceuticals Incorporated Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Kyowa Kirin Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Personalized Gene Therapy Treatment Market Other Major And Innovative Companies

31.1. BioMarin Pharmaceutical Inc.

31.2. Sarepta Therapeutics Inc.

31.3. Rocket Pharmaceuticals Inc.

31.4. REGENXBIO Inc.

31.5. Intellia Therapeutics Inc.

31.6. Beam Therapeutics Inc.

31.7. Adaptimmune Therapeutics plc

31.8. Krystal Biotech Inc.

31.9. Miltenyi Biomedicine GmbH

31.10. Bluebird Bio Inc.

31.11. uniQure N.V.

31.12. Mesoblast Limited

31.13. Astellas Gene Therapies Inc.

31.14. Adverum Biotechnologies Inc.

32. Global Personalized Gene Therapy Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Personalized Gene Therapy Treatment Market

34. Recent Developments In The Personalized Gene Therapy Treatment Market

35. Personalized Gene Therapy Treatment Market High Potential Countries, Segments and Strategies

35.1 Personalized Gene Therapy Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Personalized Gene Therapy Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Personalized Gene Therapy Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Personalized Gene Therapy Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Personalized Gene Therapy Treatment Market, Sub-Segmentation Of Targeted Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Personalized Gene Therapy Treatment Market, Sub-Segmentation Of Pharmacogenomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Personalized Gene Therapy Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Personalized Gene Therapy Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Bayer AG Financial Performance
  • Table 78: Novartis AG Financial Performance
  • Table 79: Bristol-Myers Squibb Company Financial Performance
  • Table 80: Vertex Pharmaceuticals Incorporated Financial Performance
  • Table 81: Kyowa Kirin Co. Ltd. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Personalized Gene Therapy Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Personalized Gene Therapy Treatment Market, Sub-Segmentation Of Targeted Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Personalized Gene Therapy Treatment Market, Sub-Segmentation Of Pharmacogenomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Personalized Gene Therapy Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Personalized Gene Therapy Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Personalized Gene Therapy Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Personalized Gene Therapy Treatment Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Personalized Gene Therapy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Bayer AG Financial Performance
  • Figure 78: Novartis AG Financial Performance
  • Figure 79: Bristol-Myers Squibb Company Financial Performance
  • Figure 80: Vertex Pharmaceuticals Incorporated Financial Performance
  • Figure 81: Kyowa Kirin Co. Ltd. Financial Performance

Frequently Asked Questions

Personalized gene therapy treatment refers to professional medical treatment that delivers targeted therapies tailored to an individual’s unique genetic profile. It modifies, repairs, or replaces faulty genes to directly address underlying genetic conditions. Personalized gene therapy treatment enhances treatment precision, minimizes adverse effects, and improves therapeutic effectiveness. For further insights on this market, request a sample here

The market major growth driver - The Rising Prevalence Of Genetic Disorders Is Fueling The Growth Of The Market Due To Increasing Cases That Require Targeted, Gene-Based Therapies. For further insights on this market, request a sample here

The personalized gene therapy treatment market size has grown exponentially in recent years. It will grow from $6.93 billion in 2024 to $8.38 billion in 2025 at a compound annual growth rate (CAGR) of 20.8%. The growth in the historic period can be attributed to increasing prevalence of genetic disorders, advancements in gene editing technologies, rising awareness about personalized medicine, supportive government initiatives and funding, and growth in biotechnology research and infrastructure. The personalized gene therapy treatment market size is expected to see exponential growth in the next few years. It will grow to $17.65 billion in 2029 at a compound annual growth rate (CAGR) of 20.5%. The growth in the forecast period can be attributed to the expansion of clinical trials for gene therapies, the integration of AI and predictive analytics in treatment design, increasing partnerships between pharma and biotech companies, the development of safer and more efficient delivery vectors, and the growing demand for targeted and precision therapies. Major trends in the forecast period include integration of artificial intelligence and machine learning in therapy design, expansion of genomic sequencing capabilities, rising collaborations between biotechnology and pharmaceutical companies, automation in gene therapy manufacturing processes, and integration of blockchain technology for genetic data security. For further insights on this market, request a sample here

The personalized gene therapy treatment market covered in this report is segmented as
1) By Therapy: Targeted Treatments, Pharmacogenomics
2) By Vector Type: Viral, Non-Viral
3) By Distribution Channel: Hospitals, Clinics, Home Administration, Other Distribution Channels
4) By Application: Oncology, Neurology, Hematological, Infectious Diseases, Ophthalmology, Other Applications Subsegments:
1) By Targeted Treatments: Monoclonal Antibodies, Chimeric Antigen Receptor T-Cell Therapy (CAR-T), Small Interfering RNA (siRNA) Therapy, Antisense Oligonucleotides (ASO), Gene Editing Therapy
2) By Pharmacogenomics: Companion Diagnostics, Drug Metabolism Enzyme Testing, Genetic Biomarker Analysis, Single Nucleotide Polymorphism (SNP) Profiling, Adverse Drug Reaction (ADR) Prediction For further insights on this market,
request a sample here

North America was the largest region in the personalized gene therapy treatment market in 2024. The regions covered in personalized gene therapy treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the personalized gene therapy treatment market are Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Vertex Pharmaceuticals Incorporated, Kyowa Kirin Co. Ltd., BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., Rocket Pharmaceuticals Inc., REGENXBIO Inc., Intellia Therapeutics Inc., Beam Therapeutics Inc., Adaptimmune Therapeutics plc, Krystal Biotech Inc., Miltenyi Biomedicine GmbH, Bluebird Bio Inc., uniQure N.V., Mesoblast Limited, Astellas Gene Therapies Inc., Adverum Biotechnologies Inc., Autolus Therapeutics plc. For further insights on this market, request a sample here.

Major trends in this market include Strategic Partnerships Accelerating Personalized Gene Therapy Innovations For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon